FDA.reportPublic FDA data

buprenorphine 300 MG per 1.5 ML Prefilled Syringe

RxCUI
1996192
RxNorm name
buprenorphine 300 MG per 1.5 ML Prefilled Syringe
Display name
buprenorphine 300 MG per 1.5 ML Prefilled Syringe
Full name
buprenorphine 300 MG per 1.5 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SUBLOCADEBUPRENORPHINEIndivior Inc.6189fb21-9432-45f8-8481-0bfaf3ccde952026-07-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1996192

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6189fb21-9432-45f8-8481-0bfaf3ccde95buprenorphine 300 MG in 1.5 mL Prefilled Syringe [PSN] · 1.5 ML buprenorphine 200 MG/ML Prefilled Syringe [SCD] · buprenorphine 300 MG per 1.5 ML Prefilled Syringe [SY]342These highlights do not include all the information needed to use SUBLOCADE ® safely and effectively. See full prescribing information for SUBLOCADE. SUBLOCADE (buprenorphine extended-release) injection, for subcutaneous use, CIII Initial U.S. Approval: 200220251222